1. Home
  2. Live Updates
  3. Adcendo board

Adcendo Board News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Adcendo board. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Adcendo Board Today - Breaking & Trending Today

Adcendo ApS Announces Extension of Series A Financing to EUR 98M to Further Bolster its First-in-Class ADC Pipeline

Raises additional 16M EUR led by Dawn Biopharma, a platform controlled by KKR, with participation from existing investors.Funds will be used to further strengthen growing pipeline of first in ....

Iyona Rajkomar , Michael Pehl , Healthcare Strategic Growth Fund , Novo Holdings , Dawn Biopharma , Managing Partner , Adcendo Board , Ysios Capital , Gilde Healthcare , Pontifax Venture , Development Candidate Nomination , Chief Executive Officer , Board Director , Pontifax Venture Capital , Strategic Growth Fund , Ihr Portfolio ,

Adcendo Raises €16M; Extends Series A to €98M

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time! ....

Michael Pehl , Iyona Rajkomar , Novo Holdings , Dawn Biopharma , Ysios Capital , Gilde Healthcare , Pontifax Venture , Managing Partner , Adcendo Board ,

Danish biotech startup announces extension of series A financing to €82M

Copenhagen-based biotech startup Adcendo ApS has collected an additional €31M in a Series A round led by Pontifax Venture Capital and existing investors Novo ....

Michael Pehl , Novo Holdings , Adcendo Aps , Pontifax Venture Capital , Gilde Healthcare , Adcendo Board , Development Candidate Nomination , Chief Executive Officer , Ohad Hammer , Candidate Nomination , Board Director ,

Adcendo ApS Announces Extension of Series A Financing to 82M EUR to Ensure Broad Development of its First-in-class ADC Pipeline

/PRNewswire/ Adcendo ApS ("Adcendo"), a biotech company focused on the development of breakthrough antibody-drug conjugates (ADCs) for the treatment of. ....

Michael Pehl , Novo Holdings , Pontifax Venture Capital , Ysios Capital , Gilde Healthcare , Ohad Hammer , Adcendo Board , Development Candidate Nomination , Chief Executive Officer , Candidate Nomination , Board Director ,

Adcendo Raises €31M; Extends Series A Round to €82M

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time! ....

Michael Pehl , Novo Holdings , Adcendo Aps , Pontifax Venture Capital , Gilde Healthcare , Ohad Hammer , Adcendo Board , Development Candidate Nomination ,